Oppenheimer reiterated coverage on ESSA Pharma with a new price target
$EPIX
Biotechnology: Pharmaceutical Preparations
Health Care
Oppenheimer reiterated coverage of ESSA Pharma with a rating of Outperform and set a new price target of $22.00 from $36.00 previously